Pharmacy |
| ||
|
Arimidex Generic Anastrozole |
|
| ||
Home » Prescription Drugs 2 » Arimidex Generic Anastrozole Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Arimidex is used for: Treating breast cancer in women who have been through menopause including women with disease progression after tamoxifen therapy. Arimidex is a first-line treatment of breast cancer in postmenopausal women. It slows the growth of advanced cancer within the breast and cancer that has spread to other parts of the body. ARIMIDEX is indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Patients with ER-negative disease and patients who did not respond to previous tamoxifen therapy rarely responded to ARIMIDEX. Buy Arimidex Generic Anastrozole and other Prescription Drugs 2 products online at Medstore. 3634
About Arimidex Generic Anastrozole: Product Type: Prescription Drugs 2 Arimidex ( Generic Anastrozole ) Arimidex (Generic Anastrozole) Generic Anastrozole 1mg 28 Tablets Generic Anastrozole Arimidex
View more Prescription Drugs 2 Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.
| ||
